Vectura Group PLC (VEC)

Back to homepage

Company Description

Vectura Group PLC was incorporated in the United Kingdom on August 13, 1997. The Company is a respiratory product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases. The Company is engaged in the research, development and commercialisation of novel therapeutic products and drug delivery systems for human use. These include major diseases, such as asthma and chronic obstructive pulmonary disease (COPD). It covers other indications including cough, severe inflammation, cystic fibrosis, allergic rhinitis, and fibrotic diseases of the lung. The Company has eight products marketed by partners and a portfolio of drugs in clinical development, a number of which have been licensed to pharmaceutical companies...